CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...

Increased use of GLP-1 and services for cancer and mental health are contributing factors, says Business Group on Health.

Shares of Gilead Sciences, Inc. (GILD) tumbled 2.2% on Aug. 21, after pharmacy benefit manager CVS Health (CVS) decided not ...

KHAGRACHHARI, Aug 22, 2025 (BSS) – Chittagong Hill Tracts (CHT) Affairs Adviser Supradip Chakma laid foundation stone of a ...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

As President of the Pennsylvania State Grange, I hear the same concerns from families, farmers, and small business owners across our state: prescription drug costs are too high and the ...

President Donald Trump recently set an ambitious goal – ensure that Americans pay lower prices for medicines than patients in ...

The company was valued at $1 billion in 2019, but like many other businesses, it took a beating during the pandemic.

A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...